Hefei Lifeon Pharmaceutical Co., Ltd.
SZSE:003020.SZ
25.2 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||
| Nettowinst
| 226.673 | 209.608 | 172.227 | 135.116 | 105.141 | 91.664 | 76.819 | 67.463 | 51.854 | 44.815 | 32.842 |
| Afschrijvingen & Amortisatie
| 47.342 | 36.036 | 36.916 | 15.954 | 14.956 | 13.774 | 13.296 | 13.039 | 11.066 | 11.291 | 10.446 |
| Uitgestelde Inkomstenbelasting
| 0 | -1.692 | -2.487 | 0.972 | -0.724 | -0.217 | -0.44 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -72.012 | -19.406 | -45.552 | 18.962 | 26.489 | -41.357 | -83.179 | -24.95 | 24.754 | -24.219 | -53.611 |
| Vorderingen
| -211.489 | -94.203 | -29.574 | -37.62 | -9.665 | -76.959 | -64.293 | -23.901 | 43.772 | 0.061 | -37.22 |
| Voorraden
| -39.493 | -177.098 | 1.975 | -15.757 | -11.802 | -13.195 | -0.613 | 6.92 | -29.179 | -43.441 | -23.239 |
| Crediteuren
| 175.701 | 253.586 | -15.467 | 71.367 | 48.679 | 49.015 | -17.833 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 3.269 | -1.692 | -2.487 | 0.972 | -0.724 | -28.162 | -82.566 | -31.871 | 53.933 | 19.223 | -30.372 |
| Overige Niet-Contante Posten
| 1.671 | -30.751 | -4.888 | 2.457 | 2.714 | 0.37 | 4.387 | 3.444 | 4.376 | 3.651 | 2.365 |
| Kasstroom uit Operationele Activiteiten
| 203.675 | 200.638 | 158.703 | 172.489 | 149.3 | 64.452 | 11.324 | 58.995 | 92.049 | 35.538 | -7.957 |
| Investeringsactiviteiten: | |||||||||||
| Investeringen in Materiële Vaste Activa
| -197.538 | -246.425 | -186.946 | -56.199 | -43.904 | -29.156 | -11.456 | -12.743 | -34.014 | -44.425 | -30.124 |
| Netto Overnames
| -183.528 | 0.334 | 0.267 | 0.011 | 0.106 | 0.064 | 0.09 | 0 | 0 | 0 | -6.239 |
| Aankoop van Beleggingen
| -795 | -940.021 | -1,610 | 0 | 0 | 0 | 0 | -13.5 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 884.75 | 984.308 | 1,604.8 | 0 | 0 | 22.905 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| -149.285 | 0 | 0 | -56.199 | 0 | 0.064 | 4.041 | 0.026 | 0.005 | 0.008 | 0.001 |
| Kasstroom uit Investeringsactiviteiten
| -440.6 | -201.805 | -191.879 | -56.187 | -43.799 | -6.188 | -7.415 | -26.218 | -34.009 | -44.417 | -36.362 |
| Financieringsactiviteiten: | |||||||||||
| Schuldaflossingen
| 41.994 | 0 | 0 | -24 | -11 | -30 | 15 | 0 | -22 | 32 | 42 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | -3.507 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -61.282 | -64.848 | -46.32 | -27.792 | -20.844 | -22.4 | -16.338 | -22.336 | -17.596 | -14.812 | -9.538 |
| Overige Financieringsactiviteiten
| 55.913 | 16.899 | -12.176 | 460.519 | 6.054 | 47.121 | 6.338 | 2.163 | 2.74 | 1.551 | 7.657 |
| Kasstroom uit Financieringsactiviteiten
| 36.625 | -47.949 | -58.496 | 408.441 | -25.79 | -5.28 | 5 | -20.173 | -36.856 | 18.739 | 40.119 |
| Overige Informatie: | |||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.043 | 0.403 | -0.181 | -0.488 | 0.101 | 0.041 | -0.014 | 0.034 | 0 | -0 | -0 |
| Netto Kasstroomverandering
| -74.506 | -48.712 | -91.854 | 524.256 | 79.812 | 53.025 | 8.895 | 12.638 | 21.184 | 9.859 | -4.2 |
| Kaspositie aan het Einde van de Periode
| 502.722 | 577.228 | 625.941 | 717.794 | 193.539 | 113.727 | 60.702 | 51.807 | 43.261 | 22.076 | 12.218 |